CONCENTRATIONS |
6 Months Ended |
|---|---|
Jun. 30, 2025 | |
| CONCENTRATIONS | |
| CONCENTRATIONS |
NOTE 17 - CONCENTRATIONS
Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and trade receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.
The Company’s revenues earned from sale of products and services for the three months ended June 30, 2025 included 99% from two customers of the Company’s total revenues.
The Company’s revenues earned from sale of products and services for the three months ended June 30, 2024 included 100% from three customers of the Company’s total revenues.
The Company’s revenues earned from sale of products and services for the six months ended June 30, 2025 included 99% from two customers of the Company’s total revenues.
The Company’s revenues earned from sale of products and services for the six months ended June 30, 2024 included 89% from six customers of the Company’s total revenues.
At June 30, 2025, two customers accounted for 100% of the Company’s total accounts receivable with an aggregate amount of $51,242. At December 31, 2024, the Company had $ $0 accounts receivable. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|